Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
La Revue Du Praticien
|
December 15, 1993
[Treatment of menopause and cancer of the breast: epidemiological aspects]
G Plu-Bureau
Therapie
|
September 29, 1999
[Cardiovascular risk and hormone replacement therapy in menopause]
G Plu-Bureau
La Revue Du Praticien
|
December 1, 1995
[Oral contraception and risk of cancer. Epidemiological aspects of breast and gynecological cancers]
G Plu-Bureau
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
May 11, 2000
[Hormone replacement therapy after breast cancer]
G Plu-Bureau
Annals of the New York Academy of Sciences
|
September 16, 2010
Is the decrease in breast cancer incidence related to a decrease in postmenopausal hormone therapy?
A Gompel, G Plu-Bureau
Climacteric : the Journal of the International Menopause Society
|
June 2, 2018
Progesterone, progestins and the breast in menopause treatment
A Gompel, G Plu-Bureau
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
February 1, 1993
[Quantitative evaluation of the cardiovascular risk associated with hormone substitution therapy during menopause]
P Y Scarabin, G Plu-Bureau
Contraception, Fertilite, Sexualite (1992)
|
March 1, 1995
[Women at high risk for breast cancer: can we define a group of women in France who could participate in a prevention trial?]
M G Lê, G Plu-Bureau
Gynecologie, Obstetrique, Fertilite & Senologie
|
March 24, 2021
[Menopausal hormone therapy an cardiovascular risk. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]
G Plu-Bureau, C Mounier-Vehier
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
November 4, 2015
[Post-partum contraception: Guidelines for clinical practice]
B Raccah-Tebeka, G Plu-Bureau
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
La Revue Du Praticien
|
December 15, 1993
[Treatment of menopause and cancer of the breast: epidemiological aspects]
G Plu-Bureau
Therapie
|
September 29, 1999
[Cardiovascular risk and hormone replacement therapy in menopause]
G Plu-Bureau
La Revue Du Praticien
|
December 1, 1995
[Oral contraception and risk of cancer. Epidemiological aspects of breast and gynecological cancers]
G Plu-Bureau
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
May 11, 2000
[Hormone replacement therapy after breast cancer]
G Plu-Bureau
Annals of the New York Academy of Sciences
|
September 16, 2010
Is the decrease in breast cancer incidence related to a decrease in postmenopausal hormone therapy?
A Gompel, G Plu-Bureau
Climacteric : the Journal of the International Menopause Society
|
June 2, 2018
Progesterone, progestins and the breast in menopause treatment
A Gompel, G Plu-Bureau
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
February 1, 1993
[Quantitative evaluation of the cardiovascular risk associated with hormone substitution therapy during menopause]
P Y Scarabin, G Plu-Bureau
Contraception, Fertilite, Sexualite (1992)
|
March 1, 1995
[Women at high risk for breast cancer: can we define a group of women in France who could participate in a prevention trial?]
M G Lê, G Plu-Bureau
Gynecologie, Obstetrique, Fertilite & Senologie
|
March 24, 2021
[Menopausal hormone therapy an cardiovascular risk. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]
G Plu-Bureau, C Mounier-Vehier
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
November 4, 2015
[Post-partum contraception: Guidelines for clinical practice]
B Raccah-Tebeka, G Plu-Bureau
Page
of 7